Amoy Diagnostics Co Ltd
SZSE:300685
Amoy Diagnostics Co Ltd
Inventory
Amoy Diagnostics Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amoy Diagnostics Co Ltd
SZSE:300685
|
Inventory
¥37.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Inventory
¥3B
|
CAGR 3-Years
72%
|
CAGR 5-Years
92%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Inventory
¥822.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Inventory
¥706.5m
|
CAGR 3-Years
53%
|
CAGR 5-Years
115%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Inventory
¥863.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Inventory
¥63m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amoy Diagnostics Co Ltd
Glance View
Amoy Diagnostics Co., Ltd., nestled in the bustling city of Xiamen, China, has carved out a niche in the world of molecular diagnostics. Founded in 2008, the company has quickly become a pioneer in precision medicine, focusing on the development and commercialization of technologies for the detection of genetic mutations. At the heart of its operation lies its proprietary ADx-ARMS technology, an innovative method allowing for the precise and sensitive detection of mutations in tumor tissues and blood, facilitating oncology diagnostics. This technology not only empowers oncologists with critical insights for tailored cancer treatments but underscores Amoy Diagnostics' commitment to transforming patient care through cutting-edge genetic testing. The commercial prowess of Amoy Diagnostics is, however, much more than its technological innovations. The company thrives on a robust business model that hinges on a symbiotic relationship with the pharmaceutical industry and healthcare providers. By offering diagnostic services and research kits, Amoy Diagnostics provides crucial support in the development of targeted therapies, enabling pharmaceutical companies to test and bring to market personalized medicine solutions. Their revenue stream is bolstered by strategic partnerships and licensing agreements, which allow them to expand their portfolio and market reach both domestically and internationally. This dynamic approach not only ensures a wide adoption of their diagnostic solutions but also firmly positions Amoy Diagnostics as a key player in the rapidly growing field of precision oncology.
See Also
What is Amoy Diagnostics Co Ltd's Inventory?
Inventory
37.3m
CNY
Based on the financial report for Sep 30, 2024, Amoy Diagnostics Co Ltd's Inventory amounts to 37.3m CNY.
What is Amoy Diagnostics Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
15%
Over the last year, the Inventory growth was 16%. The average annual Inventory growth rates for Amoy Diagnostics Co Ltd have been 2% over the past three years , 15% over the past five years .
You don't have any saved screeners yet